InvestorsHub Logo
Followers 2
Posts 2022
Boards Moderated 0
Alias Born 05/11/2017

Re: None

Friday, 06/28/2019 9:25:37 AM

Friday, June 28, 2019 9:25:37 AM

Post# of 108192
This is what Advaxis could be doing next -- triple set of warrants. Unbelievable! I don't remember ever seeing this type of offering. Recall Sorrento and Advaxis had a collaboration 4 years ago that quietly died next year or so.

Sorrento Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock and Warrants
https://finance.yahoo.com/news/sorrento-therapeutics-announces-pricing-underwritten-123721856.html

SAN DIEGO, June 28, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), a clinical stage, antibody-centric biopharmaceutical company developing new therapies to turn malignant cancers into manageable and possibly curable diseases, today announced the pricing of its public offering of 8,333,334 shares of its common stock, Series A warrants to purchase up to an aggregate of 8,333,334 shares of its common stock, Series B warrants to purchase up to an aggregate of 8,333,334 shares of its common stock and Series C warrants to purchase up to an aggregate of 8,333,334 shares of its common stock, at a price to the public of $3.00 per share and accompanying Series A, Series B and Series C warrant.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News